JPT2/HN1L functions as an NAADP-binding protein in a cell type-specific manner

This study demonstrates that the NAADP-binding protein JPT2/HN1L is essential for NAADP-mediated calcium signaling and T cell activation but is dispensable in cardiomyocytes, platelets, and mast cells, highlighting a striking cell-type specificity in its physiological function.

The Gist

Imagine your body is a bustling city, and inside every cell, there is a complex network of power plants and communication lines. One of the most important messengers in this city is a molecule called NAADP. Think of NAADP as a specialized delivery driver whose job is to knock on the doors of internal calcium "warehouses" to release a burst of energy (calcium) that tells the cell what to do next.

However, NAADP can't just walk through the door on its own. It needs a keyholder—a specific protein that recognizes it and unlocks the warehouse. For a long time, scientists thought the keyholder named JPT2/HN1L was the only one who could do this job for everyone in the city.

This paper is like a detective story where the researchers decided to test this theory by building a city where the JPT2/HN1L keyholder was missing. They created special mice without this protein and checked four different "neighborhoods" (cell types) to see what happened when the delivery driver showed up without his usual keyholder.

Here is what they found, explained through simple analogies:

1. The Heart Neighborhood (Cardiomyocytes)

The Scenario: The heart cells are like high-speed trains that need precise timing to beat. Sometimes, stress (like adrenaline) makes the train run wild, causing dangerous "spontaneous jumps" (arrhythmias). Scientists thought JPT2/HN1L was the conductor keeping this in check.
The Result: When they removed JPT2/HN1L, the trains kept running exactly the same. The heart cells didn't care that the keyholder was gone.
The Takeaway: In the heart, there must be a backup keyholder (possibly another protein called LSM12) who steps in immediately to do the job. The system is so robust that losing one keyholder doesn't cause a blackout.

2. The Emergency Response Team (Platelets)

The Scenario: Platelets are the city's first responders. When you get a cut, they rush to the scene and clump together to stop bleeding. This clumping is triggered by NAADP.
The Result: Even without JPT2/HN1L, the platelets still clumped together perfectly when they saw a wound.
The Takeaway: Just like in the heart, the emergency response team has a redundant system. If one keyholder is missing, another one takes the wheel, and the bleeding still stops.

3. The Allergy Squad (Mast Cells)

The Scenario: Mast cells are the body's allergy alarms. When they detect an allergen (like pollen), they explode with calcium to release histamine, causing a sneeze or a rash.
The Result: When the researchers triggered an allergic reaction in these cells without JPT2/HN1L, the alarm still went off loud and clear.
The Takeaway: The allergy squad also has a substitute keyholder. The system is flexible enough to handle the loss of JPT2/HN1L without failing.

4. The Security Guards (T-Cells)

The Scenario: T-cells are the elite security guards of the immune system. They need to spot an invader (like a virus) and sound the alarm instantly. This requires a very specific, rapid burst of calcium right at the moment of contact.
The Result: This is where the story changes. When the researchers removed JPT2/HN1L in T-cells, the security guards failed to sound the alarm. The initial burst of calcium was tiny, and the global signal was weak. The guards were confused and couldn't activate the immune response properly.
The Takeaway: In T-cells, JPT2/HN1L is the only keyholder for this specific job. There is no backup. Without this specific protein, the immune system's "start button" is broken.

The Big Picture

This study teaches us a vital lesson about biology: Context is everything.

• In the Heart, Platelets, and Allergy Cells: The system is like a car with a spare tire. If the main tire (JPT2/HN1L) is flat, the spare (LSM12) rolls out, and you can keep driving.
• In T-Cells: The system is like a high-security vault with a single, irreplaceable key. If you lose JPT2/HN1L, the vault stays locked, and the immune response cannot start.

Why does this matter?
This discovery is huge for medicine. It suggests that if we want to treat autoimmune diseases (where the immune system attacks the body) or improve organ transplants, we might be able to target only the T-cells by blocking JPT2/HN1L. We could "turn off" the immune overreaction without accidentally stopping the heart from beating or the blood from clotting, because those other cells have their own backup plans.

In short, the researchers found that while JPT2/HN1L is a VIP in the immune system, it's just a regular employee in the heart and blood cells. It's not a universal boss; it's a specialist.

Technical Summary

1. Problem Statement

Nicotinic acid adenine dinucleotide phosphate (NAADP) is a potent second messenger that mobilizes calcium ($Ca^{2+}$) from intracellular acidic stores. While the downstream channels (Two-Pore Channels TPC1/2, TRPML1, and Ryanodine Receptor RYR1) are known, NAADP cannot bind directly to these channels. Instead, it requires specific binding proteins, primarily JPT2/HN1L and LSM12, to facilitate channel activation.

Although JPT2/HN1L has been identified as an NAADP-binding protein in cell lines (e.g., Jurkat T cells, U2OS), its physiological relevance in primary cells remains unclear. It is unknown whether JPT2/HN1L is universally required for NAADP signaling across all cell types or if its function is restricted to specific tissues. Furthermore, the potential for functional redundancy with other binding proteins like LSM12 in vivo has not been systematically evaluated in a whole-organism model.

2. Methodology

The authors employed a multi-disciplinary approach combining genetic engineering, functional imaging, and pharmacology:

• Generation of Knockout Mice: Using CRISPR/Cas9 genome editing in mouse zygotes, the authors generated $Jpt2/Hn1l^{-/-}$ mice by deleting exon 3, resulting in a premature stop codon. The mice were viable and fertile.
• Validation: Protein expression was confirmed via Western blot in spleen tissue, showing a complete absence of JPT2/HN1L in knockout mice.
• Cell Types Studied: The study focused on four primary cell types known to utilize NAADP signaling:
  1. Ventricular Cardiomyocytes: Isolated via retrograde perfusion.
  2. Platelets: Isolated via submandibular bleeding.
  3. Peritoneal Mast Cells (PMCs): Isolated via peritoneal lavage and cultured with IL-3 and Stem Cell Factor.
  4. CD4+ T Cells: Isolated from spleens via negative selection.
• Functional Assays:
  • Cardiomyocytes: Electrically paced cells were stimulated with Isoprenaline (ISO) to induce $\beta$-adrenergic stress. Spontaneous diastolic $Ca^{2+}$ transients (SCTs) were measured using Fura-2 AM. The NAADP antagonist BZ194 was used as a control.
  • Platelets: Aggregation was induced by Collagen-Related Peptide (CRP), Thrombin, $\gamma$-thrombin, and PAR-4 agonists. The NAADP antagonist Ned19 was used to validate NAADP dependence.
  • Mast Cells: Antigen (DNP)-evoked $Ca^{2+}$ signaling was measured using Fura-2 AM imaging.
  • T Cells: Cells were stimulated via TCR/CD3. Global $Ca^{2+}$ elevations (Fura-2) and early $Ca^{2+}$ microdomains (Fluo4/FuraRed high-speed imaging) were analyzed.
• Compensation Analysis: qPCR was performed to check for compensatory upregulation of Lsm12 in knockout tissues.

3. Key Results

The study revealed a striking cell-type specificity in the requirement for JPT2/HN1L:

• Cardiomyocytes (No Effect):

  • In electrically paced cardiomyocytes, $\beta$-adrenergic stimulation (ISO) evoked spontaneous diastolic $Ca^{2+}$ transients (SCTs).
  • The frequency and amplitude of these SCTs were unchanged in $Jpt2/Hn1l^{-/-}$ myocytes compared to wild-type controls, even under high ISO concentrations or combined with PDE inhibition (IBMX).
  • Note: qPCR showed significant upregulation of Lsm12 in knockout cardiomyocytes, suggesting compensation.

• Platelets (No Effect):

  • Platelet aggregation induced by CRP, Thrombin, $\gamma$-thrombin, or PAR-4 agonists was unaffected by the deletion of JPT2/HN1L.
  • While the NAADP antagonist Ned19 abolished aggregation (confirming NAADP's role), the genetic absence of JPT2/HN1L did not alter the response.

• Mast Cells (No Effect):

  • Antigen-evoked (DNP) global $Ca^{2+}$ rises in peritoneal mast cells showed no difference in amplitude or Area Under the Curve (AUC) between knockout and control cells.

• CD4+ T Cells (Critical Effect):

  • Global Signaling: Upon TCR/CD3 stimulation, $Jpt2/Hn1l^{-/-}$ T cells exhibited a significant reduction in global $Ca^{2+}$ peak elevation compared to controls.
  • Microdomains: The most profound effect was observed in early $Ca^{2+}$ microdomains (occurring within tens of milliseconds of stimulation). These initiating signals were severely diminished in number and intensity in knockout T cells.
  • Basal $Ca^{2+}$ levels remained unchanged, indicating the defect is specific to stimulus-evoked signaling.
  • Note: No compensatory upregulation of Lsm12 was observed in spleen tissue (where T cells were isolated).

4. Key Contributions

• First In Vivo Validation: This is the first study to generate and characterize a whole-body $Jpt2/Hn1l$ knockout mouse, moving beyond cell-line studies to primary tissues.
• Discovery of Cell-Type Specificity: The paper definitively demonstrates that JPT2/HN1L is not a universal NAADP-binding protein. It is indispensable for NAADP-mediated signaling in T cells but dispensable in cardiomyocytes, platelets, and mast cells under the tested conditions.
• Mechanistic Insight into Redundancy: The results suggest that in cardiomyocytes, LSM12 can compensate for the loss of JPT2/HN1L (evidenced by Lsm12 upregulation and preserved function). In contrast, T cells appear uniquely dependent on JPT2/HN1L, likely due to the specific coupling of NAADP to RYR1 in this cell type, whereas other cell types may rely more on TPC channels.
• Refinement of NAADP Signaling Models: The data challenges the assumption that NAADP signaling mechanisms are uniform across tissues, highlighting that the "NAADP-binding protein" landscape is tissue-specific.

5. Significance

• Therapeutic Implications: Since JPT2/HN1L is critical for T cell activation (specifically the early microdomains required for NFAT activation and gene transcription), it represents a potential therapeutic target for immune modulation. Targeting JPT2/HN1L could fine-tune immune responses in autoimmunity, transplantation, or cancer immunotherapy without affecting cardiac function or hemostasis (platelet aggregation).
• Understanding Arrhythmogenesis: The finding that JPT2/HN1L is dispensable for catecholamine-induced arrhythmogenic $Ca^{2+}$ transients in cardiomyocytes clarifies that other mechanisms (likely LSM12 or TPCs directly) drive this pathology, redirecting future drug discovery efforts.
• Biological Paradigm: The study underscores the complexity of second messenger systems, where a single messenger (NAADP) utilizes different protein partners (JPT2 vs. LSM12) depending on the cellular context to achieve specific physiological outcomes.